Integer Holdings ITGR
NYSE ITGR
$125.20 -0.01 (-0.01%)
At close: Aug 21, 2026 · 4:00 PM EDT

Integer Holdings (ITGR) Cash from Financing Activities (2010 - 2026)

Integer Holdings (ITGR) posted Cash from Financing Activities of $3.8 million for Q2 2026, up 106.21% sequentially from -$61.7 million in Q4 2025, and down 97.47% YoY from $151.6 million in Q2 2025.

Integer Holdings (ITGR) Cash from Financing Activities (2010 - 2026) Analysis & Trends

Integer Holdings has reported Cash from Financing Activities for 17 years, with the latest figure at $3.8 million in Q2 2026.

  • Quarterly Cash from Financing Activities fell 97.47% year-over-year to $3.8 million in Q2 2026, while the trailing twelve-month figure through Apr 2026 was -$104.2 million (down 6591.59% YoY) and the FY2025 annual result came in at $43.6 million, up 226.99% from the prior year.
  • Cash from Financing Activities improved to $3.8 million in Q2 2026 per ITGR's latest filing, from -$61.7 million in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $163.3 million in Q1 2024 and troughed at -$82.3 million in Q4 2024.
  • A 5-year average of $8.0 million and a median of -$10.7 million in 2025 frame the typical range for Cash from Financing Activities.
  • The sharpest annual moves came in 2023 and 2024: Cash from Financing Activities jumped 3321.4% in 2023, then tumbled 569.69% in 2024.
  • Over 5 years, Cash from Financing Activities stood at -$13.9 million in 2022, then soared by 225.74% to $17.5 million in 2023, then sank by 569.69% to -$82.3 million in 2024, then advanced by 25.01% to -$61.7 million in 2025, then jumped by 106.21% to $3.8 million in 2026.
  • According to Business Quant data, Cash from Financing Activities over the past three periods registered $3.8 million, -$61.7 million, and -$10.7 million for Q2 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Abbott Laboratories 202.72 Bn 197.12 Bn 7.27 Bn -3.52 Bn
2 Stryker 126.42 Bn 122.94 Bn 4.50 Bn -95.00 Mn
3 Medtronic 119.75 Bn 110.53 Bn 6.41 Bn -888.00 Mn
4 Boston Scientific 74.13 Bn 73.60 Bn 3.85 Bn -410.00 Mn
5 Edwards Lifesciences 51.78 Bn 47.53 Bn 1.35 Bn -300,000.00
6 Dexcom 35.29 Bn 33.34 Bn 830.00 Mn -607.30 Mn
7 GE HealthCare Technologies 33.95 Bn 31.85 Bn 2.18 Bn -236.00 Mn
8 Koninklijke Philips 26.22 Bn 22.90 Bn 4.55 Bn -1.34 Bn
9 Steris 23.21 Bn 22.73 Bn 684.20 Mn -213.50 Mn
10 Integer Holdings 4.26 Bn 4.24 Bn 112.94 Mn -23.59 Mn

Historic Data

Download Data
DateValue
Jul 3, 2026 -23.59 Mn
Jul 3, 2026 -23.59 Mn
Apr 3, 2026 3.83 Mn
Apr 3, 2026 3.83 Mn
Dec 31, 2025 -61.72 Mn
Dec 31, 2025 -61.72 Mn
Sep 26, 2025 -10.71 Mn
Sep 26, 2025 -10.71 Mn
Jun 27, 2025 -35.59 Mn
Jun 27, 2025 -35.59 Mn
Mar 28, 2025 151.58 Mn
Mar 28, 2025 151.58 Mn
Dec 31, 2024 -82.30 Mn
Dec 31, 2024 -82.30 Mn
Sep 27, 2024 -43.14 Mn
Sep 27, 2024 -43.14 Mn
Jun 28, 2024 -24.53 Mn
Jun 28, 2024 -24.53 Mn
Mar 29, 2024 163.29 Mn
Mar 29, 2024 163.29 Mn